Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;43(6):1610-20.
doi: 10.1183/09031936.00036813. Epub 2013 Oct 31.

Predictors of dyspnoea prevalence: results from the BOLD study

Affiliations

Predictors of dyspnoea prevalence: results from the BOLD study

Rune Grønseth et al. Eur Respir J. 2014 Jun.

Abstract

Dyspnoea is a cardinal symptom for cardiorespiratory diseases. No study has assessed worldwide variation in dyspnoea prevalence or predictors of dyspnoea. We used cross-sectional data from population-based samples in 15 countries of the Burden of Obstructive Lung Disease (BOLD) study to estimate prevalence of dyspnoea in the full sample, as well as in an a priori defined low-risk group (few risk factors or dyspnoea-associated diseases). Dyspnoea was defined by the modified Medical Research Council questions. We used ordered logistic regression analysis to study the association of dyspnoea with site, sex, age, education, smoking habits, low/high body mass index, self-reported disease and spirometry results. Of the 9484 participants, 27% reported any dyspnoea. In the low-risk subsample (n=4329), 16% reported some dyspnoea. In multivariate analyses, all covariates were correlated to dyspnoea, but only 13% of dyspnoea variation was explained. Females reported more dyspnoea than males (odds ratio ∼2.1). When forced vital capacity fell below 60% of predicted, dyspnoea was much more likely. There was considerable geographical variation in dyspnoea, even when we adjusted for known risk factors and spirometry results. We were only able to explain 13% of dyspnoea variation.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Prevalence of mMRC-defined dyspnea grades by site in 15 countries of the BOLD study.
Figure 2
Figure 2. Prevalence of mMRC grade 2 or higher dyspnea by FVC (% predicted) and FEV1/FVC (% predicted) in participants with a lower risk for dyspnea (stapled lines), and subjects with higher risk for dyspnea (solid lines), stratified by sex.
See the text or footnotes of Table 2 for the definition the low-risk group and for number of participants.
Figure 3
Figure 3. Box-plot of FVC % predicted by mMRC dyspnea.
The box represents the interquartile range (IQR), the line within the box is the median value and the whiskers shows values within 1.5 IQR of the adjacent quartile. Outliers are plotted.
Figure 4
Figure 4. Odds ratio (logistic regression) for mMRC 2 and higher dyspnea at different levels of FVC of % predicted.
Adjusted for all covariates in table 3 except lung function variables. N=9,334.
Figure 5
Figure 5. Odds ratio (logistic regression) for mMRC 2 and higher dyspnea at different levels of FEV1/FVC (% predicted, not absolute).
Adjusted for all covariates in table 3 except lung function variables. N= 9,334.

Comment in

References

    1. Frostad A, Soyseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med. 2006;259:520–529. - PubMed
    1. The World Health Organization (WHO) [Last accessed 04.10.2011];The global burden of disease. 2004 update. Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/
    1. Bestall JJC, Paul EEA, Garrod RR, Garnham RR, Jones PPW, Wedzicha JJA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586. - PMC - PubMed
    1. Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax. 2012;67:117–121. - PubMed
    1. Lindstrom M, Kotaniemi J, Jonsson E, Lundback B. Smoking, respiratory symptoms, and diseases: a comparative study between northern Sweden and northern Finland: report from the FinEsS study. Chest. 2001;119:852–861. - PubMed

Publication types